APPLICATION
NDA208183
TYPE
NDA
ORIGINAL APPROVAL
2015-11-06
LATEST ACTION
2020-08-27
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Prescription
Products
ULTRAVATE · ReferencePrescription
HALOBETASOL PROPIONATE 0.05% · LOTION · TOPICAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.